"First in Human" documentary features CCR: The nation's cancer center

Media Inquiries

If you are interested in interviewing a CCR scientist, OR you are a scientist who has been contacted by a member of the media, please contact the NCI Press Office at ncipressofficers@mail.nih.gov or by phone at 240.760.6600.

News and Events

New findings highlight shared features of human and canine osteosarcoma

Molecular signatures of canine osteosarcoma prognosis could also predict clinical outcomes for human osteosarcomas.

Cells’ decision to divide is reversible

Surprising findings show that cells that are preparing to divide can return to a resting state if they lose growth signals, even after they have passed what was previously thought to be a point of no return.

Drug combination provides a one-two punch attack against colorectal cancer

Researchers have identified a drug that, when combined with TOP1 inhibitors, results in improved efficacy in human colorectal cancer models — a finding that may apply to other cancers treated with TOP1 inhibitors. The results also yield important insights into our basic understanding of DNA replication and repair.

Clinical trial researching immunotherapy for tumors with specific genetic deficiencies

Mary Frances Wedekind Malone, D.O., Assistant Research Physician in the Pediatric Oncology Branch, is researching immunotherapy for SMARCB1- and SMARCA4-deficient tumors.

Clinical trial researching therapy for recurrent respiratory papillomatosis

Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is leading a trial researching drug therapy for recurrent respiratory papillomatosis.

Clinical trial researching T-cell therapy for epithelial cancers

Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is leading a trial researching T-cell therapy for gastric, breast, cervical, lung and other types of epithelial cancers.

Targeting sugar-molecule tags to proteins in the treatment of aggressive lymphomas

CCR researchers, led by Louis M. Staudt, M.D., Ph.D., have discovered a novel approach to treating diffuse large B-cell lymphoma with potentially fewer treatment-related side effects. Their work identifies and exploits the role of sugar-molecule modifications in B-cell survival.

Clinical trial researches therapy for pancreatic acinar cell carcinoma (PACC)

A clinical trial led by Christine Campo Alewine, M.D. Ph.D., Lasker Clinical Research Scholar in the Laboratory of Molecular Biology, is researching a therapy for pancreatic acinar cell carcinoma (PACC), a rare type of pancreatic tumor.

Clinical trial researching therapy for aggressive blood cancers

A clinical trial led by Christopher J. Melani, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is researching a combination drug therapy for aggressive blood cancers, such as non-Hodgkin lymphomas.

Aligned Blog: Exploring the Model Minority Myth

May is Asian American and Native Hawaiian/Pacific Island Heritage (AANHPI) month! This month provides an opportunity to celebrate the contributions of the AANHPI community to society, culture and beyond. This year, I challenged myself to learn about something new: the Model Minority Myth. What is the myth and how does it affect the AANHPI community?

Clinical trial researches therapy for metastatic melanoma or renal cell carcinoma

A clinical trial led by Stephanie L. Goff, M.D., Associate Research Physician in the Surgery Branch, is researching a therapy for people with metastatic melanoma or renal cell carcinoma.

Breadcrumb

News and Events